• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肌肉注射乙型肝炎免疫球蛋白后的摄取与消除

Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.

作者信息

Scheiermann N, Kuwert E K

出版信息

Dev Biol Stand. 1983;54:347-55.

PMID:6653890
Abstract

Hepatitis B immunoglobulins of 4 different manufacturers were administered intramuscularly into 37 healthy adults. Each person received an amount of 0.1 ml per kg bodyweight. Blood samples were taken on days 3, 7, 14, 21, 28, 63, 98 and 126 after passive immunization. The anti-HBs serum levels were determined using the International Reference Preparation of anti-HBs as standard reagent. The highest serum levels were seen on day 3 (38.9% of the test persons), day 7 (41.7%), day 14 (11.1%), and day 21 (8.3%) after application of the immunoglobulins with mean values between 138 and 355 mU anti-HBs/ml. The half-life of the preparations in man showed mean values between 17.5 and 25 days. The shortest half-life was 5.9 and the longest 35 days. Four months after passive immunization the anti-HBs levels had decreased to a percentage of 1.2 to 2.5 of the maximum serum concentration (1.7 to 8.9 mU anti-HBs/ml). The passive immunization via the intramuscular route does not accomplish an instantaneously available, maximum anti-HBs titer. There seems to be a great range of variation in uptake and elimination of the immunoglobulins in man. Still, since preparations for intravenous application are not at hand, hepatitis B immunoglobulins for intramuscular use must play a major role in post-exposure prophylaxis of hepatitis B virus infection.

摘要

将4个不同厂家生产的乙型肝炎免疫球蛋白经肌肉注射给37名健康成年人。每人按每千克体重0.1毫升的剂量给药。在被动免疫后的第3、7、14、21、28、63、98和126天采集血样。以抗-HBs国际参考制品作为标准试剂测定抗-HBs血清水平。免疫球蛋白应用后,在第3天(38.9%的受测者)、第7天(41.7%)、第14天(11.1%)和第21天(8.3%)观察到最高血清水平,抗-HBs平均值在138至355 mU/ml之间。这些制剂在人体中的半衰期平均值在17.5至25天之间。最短半衰期为5.9天,最长为35天。被动免疫四个月后,抗-HBs水平已降至最大血清浓度的1.2%至2.5%(1.7至8.9 mU抗-HBs/ml)。通过肌肉注射途径进行的被动免疫不能立即达到最大抗-HBs效价。人体对免疫球蛋白的摄取和消除似乎存在很大差异。尽管如此,由于没有静脉用制剂,肌肉注射用乙型肝炎免疫球蛋白在乙型肝炎病毒感染的暴露后预防中仍必须发挥主要作用。

相似文献

1
Uptake and elimination of hepatitis B immunoglobulins after intramuscular application in man.人肌肉注射乙型肝炎免疫球蛋白后的摄取与消除
Dev Biol Stand. 1983;54:347-55.
2
[Uptake and elimination of hepatitis B immunoglobulin after intramuscular administration].[肌内注射后乙肝免疫球蛋白的摄取与消除]
Dtsch Med Wochenschr. 1982 Dec 17;107(50):1918-22. doi: 10.1055/s-2008-1070233.
3
Recovery and turnover rate of hepatitis B immunoglobulin in volunteers.志愿者中乙型肝炎免疫球蛋白的回收率和周转率
Dev Biol Stand. 1983;54:341-5.
4
Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.对于肌内注射乙型肝炎病毒疫苗无反应的HIV感染者,皮内注射重组乙型肝炎病毒免疫制剂疗效不佳。
HIV Med. 2007 Jul;8(5):295-9. doi: 10.1111/j.1468-1293.2007.00473.x.
5
[Prevention of HBs antigen-positive serum hepatitis with hyperimmune-globulin anti-HBs].用高效价抗-HBs免疫球蛋白预防HBs抗原阳性血清性肝炎
Dtsch Med Wochenschr. 1976 Apr 30;101(18):690-3. doi: 10.1055/s-0028-1104161.
6
Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.慢性乙型肝炎肝移植后乙肝表面抗原抗体的产生
Hepatology. 2003 Jan;37(1):36-43. doi: 10.1053/jhep.2003.50035.
7
The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.对采用标准免疫方法无反应的血液透析患者进行多剂量皮内乙肝疫苗再接种的有效性评估。
Przegl Lek. 2007;64(7-8):470-5.
8
[A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].[对乙肝疫苗无应答儿童再接种效果的五年观察]
Zhonghua Yu Fang Yi Xue Za Zhi. 2006 Jan;40(1):8-12.
9
Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.肝移植患者中两种乙型肝炎免疫球蛋白的免疫反应性和药代动力学比较。
Hepatology. 1999 Apr;29(4):1299-305. doi: 10.1002/hep.510290446.
10
Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.慢性乙型肝炎病毒感染患者中乙肝表面抗原(HBsAg)与异源亚型特异性抗-HBsAg抗体的共存情况。
Clin Infect Dis. 2007 May 1;44(9):1161-9. doi: 10.1086/513200. Epub 2007 Mar 19.

引用本文的文献

1
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review.接种疫苗的医护人员体内抗SARS-CoV-2抗体滴度的动态变化:一项系统文献综述
Vaccines (Basel). 2024 Dec 16;12(12):1419. doi: 10.3390/vaccines12121419.
2
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.乙型肝炎病毒感染的筛查和检测:美国疾病预防控制中心推荐 - 2023 年。
MMWR Recomm Rep. 2023 Mar 10;72(1):1-25. doi: 10.15585/mmwr.rr7201a1.
3
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited.
非线性利妥昔单抗药代动力学与抗中性粒细胞胞浆抗体(ANCA)在 ANCA 相关性血管炎中的复杂关系:重新审视 RAVE 试验。
Clin Pharmacokinet. 2020 Apr;59(4):519-530. doi: 10.1007/s40262-019-00826-5.
4
Plasma cell survival in the absence of B cell memory.浆细胞在缺乏 B 细胞记忆的情况下的存活。
Nat Commun. 2017 Nov 24;8(1):1781. doi: 10.1038/s41467-017-01901-w.
5
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?如何提高1型艾滋病毒包膜蛋白(HIV-type-1-Env)的免疫原性以促进基于抗体的疫苗开发?
AIDS Res Hum Retroviruses. 2012 Jan;28(1):1-15. doi: 10.1089/aid.2011.0053. Epub 2011 May 20.
6
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.决定浆细胞寿命和体液免疫持续时间的机制。
Immunol Rev. 2010 Jul;236(1):125-38. doi: 10.1111/j.1600-065X.2010.00912.x.
7
Immunoprophylaxis of hepatitis B in India.
Indian J Pediatr. 1988 Sep-Oct;55(5):675-80. doi: 10.1007/BF02734285.